Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Uncovering cell-type-specific neurodegeneration resilience mechanisms

Ziel

Neurodegenerative diseases (NDs) are an immense burden to patients, their families and society. For decades, they have been defined by two core characteristics. First, different NDs are characterized by the deposition of different toxic proteins in the nervous system, which are critical drivers of disease. Secondly, in different NDs different neuron subtypes are preferentially lost. Uncovering causal mechanisms explaining this selective neuronal vulnerability in NDs has remained difficult due to technical limitations. Here, I will comprehensively model this experimentally to establish the missing link and uncover the molecular mechanisms of how ND-causing toxic proteins cause selective neuronal vulnerability, and how resilient neurons survive. I will use an innovative Drosophila-human cross-species approach that I developed. As a discovery tool, we will perform parallelized single-cell RNA sequencing (scRNA-seq) of hundreds of different mature Drosophila neuron types that are exposed to defined amounts of toxic proteins. Based on the differential responses we will be able to build a holistic atlas of neuron-type-intrinsic vulnerability and resilience mechanisms in response to ND-causing toxic proteins. These will be computationally mapped to human, experimentally assessed in patient brains, and causal mechanisms established in in vivo modifier experiments in flies. We will also assess shared resilience mechanisms, since co-pathology of multiple toxic proteins is common. Therefore, we will employ concomitant protein detection and scRNA-seq to differentiate neuron-type-specific pathways that protect from toxic protein build-up vs. those that protect from the downstream cellular damage. Thereby, we will advance a fundamental scientific question and reverse engineer the brains‘ own resilience mechanisms for a new class of ND treatment targets.

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-ERC - HORIZON ERC Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) ERC-2026-STG

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Gastgebende Einrichtung

MEDIZINISCHE UNIVERSITAT INNSBRUCK
Netto-EU-Beitrag
€ 1 499 925,00
Adresse
CHRISTOPH PROBST PLATZ 1
6020 INNSBRUCK
Österreich
Region
Westösterreich Tirol Innsbruck
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 1 499 925,00

Begünstigte (1)